Tore Saxne
171 – 180 of 247
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relations to pulmonary involvement
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Nya läkemedel mot reumatoid artrit : Förbättrade behandlingsmöjligheter ställer nya krav på sjukvårdsorganisationen
(
- Contribution to journal › Article
- 1999
-
Mark
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with osteoarthritis-related type II collagen gene COL2A1 mutation
(
- Contribution to journal › Article
-
Mark
Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis
(
- Contribution to journal › Article
-
Mark
Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978
(
- Contribution to journal › Article
-
Mark
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
(
- Contribution to journal › Article
-
Mark
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
(
- Contribution to journal › Article
- 1998
-
Mark
Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint
(
- Contribution to journal › Article
-
Mark
Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis
(
- Contribution to journal › Article